Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;18(2):138-46.
doi: 10.1002/mpr.285.

A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder

Ira H Bernstein  1 , A John Rush, Trisha Suppes, Madhukar H Trivedi, Ada Woo, Yasushi Kyutoku, M Lynn Crismon, Ellen Dennehy, Thomas J Carmody
Affiliations

A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder

Ira H Bernstein et al. Int J Methods Psychiatr Res. 2009 Jun.

Abstract

The clinician-rated, 16-item Quick Inventory of Depressive Symptomatology (QIDS-C16) has been extensively evaluated in patients with major depressive disorder (MDD). This report assesses the psychometric properties of the QIDS-C16 in outpatients with bipolar disorder (BD, N = 405) and MDD (N = 547) and in bipolar patients in the depressed phase only (BD-D) (N = 99) enrolled in the Texas Medication Algorithm Project (TMAP) using classical test theory (CTT) and the Samejima graded item response theory (IRT) model. Values of coefficient alpha were very similar in BD, MDD, and BD-D groups at baseline (alpha = 0.80-0.81) and at exit (alpha = 0.82-0.85). The QIDS-C16 was unidimensional for all three groups. MDD and BD-D patients (n = 99) had comparable symptom levels. The BD-D patients (n = 99) had the most, and bipolar patients in the manic phase had the least depressive symptoms at baseline. IRT analyses indicated that the QIDS-C16 was most sensitive to the measurement of depression for both MDD patients and for BD-D patients in the average range. The QIDS-C16 is suitable for use with patients with BD and can be used as an outcome measure in trials enrolling both BD and MDD patients.

PubMed Disclaimer

References

    1. American Psychiatric Association (APA) . (2000) Diagnostic and Statistical Manual of Mental Disorders (4th ed., Text Revision), American Psychiatric Press.
    1. Bech P., Rafaelsen O.J. (1980) The use of rating scales exemplified by a comparison of the Hamilton and the Bech–Rafaelsen Melancholia Scale. Acta Psychiatrica Scandinavica, 62, 128–132.
    1. Berk M., Malhi G.S., Mitchell P.B., Cahill C.M., Carman A.C., Hadzi‐Pavlovic D., Hawkins M.T., Tohen M. (2004) Scale matters: The need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatrica Scandinavica Supplement, 422, 39–45. - PubMed
    1. Chioqueta A.P., Stiles T.C. (2003) Suicide risk in outpatients with specific mood and anxiety disorders. Crisis, 24, 105–112. - PubMed
    1. Gilbert D.A., Altshuler K.Z., Rago W.V., Shon S.P., Crismon M.L., Toprac M.G., Rush A.J. (1998) Texas Medication Algorithm Project: Definitions, rationale, and methods to develop medication algorithms. Journal of Clinical Psychiatry, 59, 345–351. - PubMed

Publication types